Shortcomings of the Korean Government's Policies to Combat the COVID-19 Pandemic and Suggestions for Improvement.
作者信息
Ma Sang Hyuk
机构信息
Department of Pediatrics, Fatima Hospital, Changwon, Korea.
出版信息
J Korean Med Sci. 2021 May 31;36(21):e156. doi: 10.3346/jkms.2021.36.e156.
Abstract
摘要
相似文献
1
Shortcomings of the Korean Government's Policies to Combat the COVID-19 Pandemic and Suggestions for Improvement.韩国政府抗击新冠疫情政策的不足之处及改进建议。
J Korean Med Sci. 2021 May 31;36(21):e156. doi: 10.3346/jkms.2021.36.e156.
2
Searching for Digital Technologies in Containment and Mitigation Strategies: Experience from South Korea COVID-19.搜索遏制和缓解策略中的数字技术：来自韩国 COVID-19 的经验。
Ann Glob Health. 2020 Aug 31;86(1):109. doi: 10.5334/aogh.2993.
3
The South Korean Government's Response to Combat COVID-19 Misinformation: Analysis of "Fact and Issue Check" on the Korea Centers for Disease Control and Prevention Website.韩国政府应对新冠疫情虚假信息的举措：对韩国疾病控制与预防中心网站“事实与问题核查”的分析
Asia Pac J Public Health. 2021 Jul;33(5):620-622. doi: 10.1177/10105395211014705. Epub 2021 May 6.
4
Statistical Estimation of Effects of Implemented Government Policies on COVID-19 Situation in South Korea.统计估计实施的政府政策对韩国 COVID-19 疫情状况的影响。
Int J Environ Res Public Health. 2021 Feb 22;18(4):2144. doi: 10.3390/ijerph18042144.
5
Flattening the Curve on COVID-19: South Korea's Measures in Tackling Initial Outbreak of Coronavirus.新冠肺炎疫情曲线趋平：韩国应对冠状病毒初始爆发的措施。
Am J Epidemiol. 2021 Apr 6;190(4):496-505. doi: 10.1093/aje/kwaa217.
6
Public Health Strategies Contain and Mitigate COVID-19: A Tale of Two Democracies.公共卫生策略遏制并缓解新冠疫情：两个民主国家的故事
Am J Med. 2020 Dec;133(12):1365-1366. doi: 10.1016/j.amjmed.2020.08.001. Epub 2020 Aug 15.
7
Effective Control of COVID-19 in South Korea: Cross-Sectional Study of Epidemiological Data.韩国有效控制 COVID-19：基于流行病学数据的横断面研究。
J Med Internet Res. 2020 Dec 10;22(12):e22103. doi: 10.2196/22103.
8
Citizens' Adherence to COVID-19 Mitigation Recommendations by the Government: A 3-Country Comparative Evaluation Using Web-Based Cross-Sectional Survey Data.公民对政府新冠疫情缓解建议的遵守情况：基于网络横断面调查数据的三国比较评估
J Med Internet Res. 2020 Aug 11;22(8):e20634. doi: 10.2196/20634.
9
Government Initiatives for Research Ethics During COVID-19 Pandemic in Korea.韩国 COVID-19 大流行期间的研究伦理政府倡议。
J Korean Med Sci. 2024 Apr 1;39(12):e116. doi: 10.3346/jkms.2024.39.e116.
10
What factors drive the satisfaction of citizens with governments' responses to COVID-19?哪些因素驱动公民对政府应对 COVID-19 措施的满意度？
Int J Infect Dis. 2021 Jan;102:327-331. doi: 10.1016/j.ijid.2020.10.050. Epub 2020 Oct 25.
本文引用的文献
1
Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.医护人员接种 ChAdOx1 nCoV-19 或 BNT162b2 mRNA COVID-19 疫苗第一针后出现的不良事件：单中心经验。
J Korean Med Sci. 2021 Apr 12;36(14):e107. doi: 10.3346/jkms.2021.36.e107.
2
Symptoms and Characteristics Which Require Attention During COVID-19 Screening at a Port of Entry.入境口岸对 COVID-19 进行筛查时需要注意的症状和特征。
J Korean Med Sci. 2021 Jan 11;36(2):e14. doi: 10.3346/jkms.2021.36.e14.
3
Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.韩国第三代 COVID-19 感染传播者索引患者病例：应用洛匹那韦/利托那韦定量 RT-PCR 监测 COVID-19 感染肺炎的治疗。
J Korean Med Sci. 2020 Feb 17;35(6):e79. doi: 10.3346/jkms.2020.35.e79.
4
The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures.韩国首例中国武汉输入性 2019 新型冠状病毒肺炎病例：感染防控措施启示。
J Korean Med Sci. 2020 Feb 10;35(5):e61. doi: 10.3346/jkms.2020.35.e61.
Zotero 插件